2nd Quarter - Report

CALIFORNIA LIFE SCIENCES for CALIFORNIA LIFE SCIENCES

Firm
Client
Income
—
Expenses
$110,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

6 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

FDA review process consistency and predictability. Address concerns with Medicare Independent Payment Advisory Board (IPAB). Address concerns with changes to Medicare Part B and Part D programs. Support reauthorization of FDA user fee programs.

LobbyistCovered position, as disclosed
JENNIFER NIETO CAREY —
ADAM LOTSPIKE New —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Taxation/Internal Revenue Code TAX

Support repeal of medical device tax. Support extension of R&D tax credit. Oppose repeal of Orphan Drug Tax Credit. Support extension of biofuel and biodiesel tax credits.

LobbyistCovered position, as disclosed
JENNIFER NIETO CAREY —
ADAM LOTSPIKE New —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Copyright/Patent/Trademark CPT

Address concerns with provisions of patent litigation reform, including inter partes review. Educate on Bayh-Dole Act "march-in" provision.

LobbyistCovered position, as disclosed
JENNIFER NIETO CAREY —
ADAM LOTSPIKE New —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Medicare/Medicaid MMM

Address concerns with Medicare Independent Payment Advisory Board (IPAB). Address concerns with changes to Medicare Part B and Part D programs, and Hospital Outpatient Prospective Payment System. Address concerns with Medicaid coverage of specialty drugs. Support creation of incentives for antibiotics development. Oppose changes to Medicare Advantage and Part D prescription drug benefit. Support the Ensuring Patient Access to Critical Breakthrough Products Act.

LobbyistCovered position, as disclosed
JENNIFER NIETO CAREY —
ADAM LOTSPIKE New —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Budget/Appropriations BUD

Labor/HHS/Ed Appropriations: NIH, biodefense/pandemic, science/math education, and strategic stockpile funding and preparation; FDA Appropriations; PTO Appropriations.

LobbyistCovered position, as disclosed
JENNIFER NIETO CAREY —
ADAM LOTSPIKE New —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Medical/Disease Research/Clinical Labs MED

Support NIH research funding. Support implementation of 21st Century Cures Act. Support legislation to improve medical device facility inspections processes.

LobbyistCovered position, as disclosed
JENNIFER NIETO CAREY —
ADAM LOTSPIKE New —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.